EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A Comprehensive Prognostic Model for Colon Adenocarcinoma Depending on Nuclear-Mitochondrial-Related Genes

Lingling Lv iD, Yuqing Huang, Qiong Li, Yuan Wu, Lan Zheng

Technology in Cancer Research & Treatment · 2024

DOI: 10.1177/15330338241258570 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Technology in Cancer Research & Treatment, 2024. Verfasst von Lingling Lv und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traditional Chinese Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Colonic Neoplasms, Adenocarcinoma, Biomarkers, Tumor, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Shanghai Integrated Traditional Chinese and Western Medicine Flagship Hospital Project, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Colon adenocarcinoma (COAD) has increasing incidence and is one of the most common malignant tumors. The mitochondria involved in cell energy metabolism, oxygen free radical generation, and cell apoptosis play important roles in tumorigenesis and progression. The relationship between mitochondrial genes and COAD remains largely unknown.

Methods

COAD data including 512 samples were set out from the UCSC Xena database. The nuclear mitochondrial-related genes (NMRGs)-related risk prognostic model and prognostic nomogram were constructed, and NMRGs-related gene mutation and the immune environment were analyzed using bioinformatics methods. Then, a liver metastasis model of colorectal cancer was constructed and protein expression was detected using Western blot assay.

Results

A prognostic model for COAD was constructed. Comparing the prognostic model dataset and the validation dataset showed considerable correlation in both risk grouping and prognosis. Based on the risk score (RS) model, the samples of the prognostic dataset were divided into high risk group and low risk group. Moreover, pathologic N and T stage and tumor recurrence in the two risk groups were significantly different. The four prognostic factors, including age and pathologic T stage in the nomogram survival model also showed excellent predictive performance. An optimal combination of nine differentially expressed NMRGs was finally obtained, including LARS2, PARS2, ETHE1, LRPPRC, TMEM70, AARS2, ACAD9, VARS2, and ATP8A2. The high-RS group had more inflamed immune features, including T and CD4 + memory cell activation. Besides, mitochondria-associated LRPPRC and LARS2 expression levels were increased in vivo xenograft construction and liver metastases assays.

Conclusion

This study established a comprehensive prognostic model for COAD, incorporating nine genes associated with nuclear-mitochondrial functions. This model demonstrates superior predictive performance across four prognostic factors: age, pathological T stage, tumor recurrence, and overall prognosis. It is anticipated to be an effective model for enhancing the prognosis and treatment of COAD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colonic NeoplasmsAdenocarcinomaBiomarkers, TumorGene Expression Regulation, NeoplasticHumansPrognosisMiceAnimalsNomogramsComputational BiologyGenes, MitochondrialDisease Models, AnimalLiver NeoplasmsGene Expression ProfilingNeoplasm StagingMaleDatabases, GeneticMitochondriaFemale

Stichwörter der Autor:innen

colon adenocarcinomanuclear mitochondrial-related genesrisk prognostic model

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Traditional Chinese Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.

ORCID-Profile: Lingling Lv

Förderung

  • Shanghai Integrated Traditional Chinese and Western Medicine Flagship Hospital Project
  • National Natural Science Foundation of China

Zitieren

APA

Lv, L., Huang, Y., Li, Q., Wu, Y., & Zheng, L. (2024). A Comprehensive Prognostic Model for Colon Adenocarcinoma Depending on Nuclear-Mitochondrial-Related Genes. Technology in Cancer Research & Treatment. https://doi.org/10.1177/15330338241258570

Vancouver

Lv L, Huang Y, Li Q, Wu Y, Zheng L. A Comprehensive Prognostic Model for Colon Adenocarcinoma Depending on Nuclear-Mitochondrial-Related Genes. Technology in Cancer Research & Treatment. 2024. doi:10.1177/15330338241258570

BibTeX
@article{Lv2024,
  author = {Lv, Lingling and Huang, Yuqing and Li, Qiong and Wu, Yuan and Zheng, Lan},
  title = {A Comprehensive Prognostic Model for Colon Adenocarcinoma Depending on Nuclear-Mitochondrial-Related Genes},
  journal = {Technology in Cancer Research & Treatment},
  year = {2024},
  doi = {10.1177/15330338241258570}
}
Kostenlos starten →